The American Academy of Orthopaedic Surgeons is investing in research and development for biologics in a five-year initiative announced on Nov. 20.
AAOS will focus on generating evidence-based, unbiased information and educational content to guide orthopedic surgeons and their patients in the field.
It plans to identify and build on the biologic gaps in musculoskeletal treatment and tackle the issue of misinformation, which stems from direct-to-consumer marketing of biologic treatments.
The organization will conduct literature reviews and symposia discussions as well as develop white paper and consensus statements to grow biologic knowledge and its application to musculoskeletal care.